OBJECTIVE: There is increasing physiological evidence in rodents connecting the neuropeptide galanin to triglyceride (TG) levels. We hypothesized that variation in the galanin preproprotein (GAL) gene may contribute to hypertriglyceridemia (HTG) in humans. METHODS AND RESULTS: We investigated GAL as a TG candidate gene by genotyping 4 tagSNPs in Dutch, Finnish, and Mexican familial combined hyperlipidemia (FCHL) families as well as in white combined hyperlipidemia cases/controls (n=2471). The common allele of rs2187331, residing in the promoter region of GAL, was significantly associated with HTG (probability value=0.00038). In an unascertained population sample of 4463 Finnish males, the rare allele of rs2187331 was associated with higher TGs (probability value=0.0028 to 0.00016). We also observed an allele specific difference with rs2187331 in reporter gene expression and nuclear factor binding in vitro. Furthermore, we detected differential expression of many key lipid genes in adipose tissue based on rs2187331 genotypes. CONCLUSIONS: The SNP rs2187331 is associated with HTG in FCHL and white combined hyperlipidemia cases/controls and influences TG levels in the population. Further studies are warranted to elucidate the allelic difference observed between FCHL and the general population. Functional evidence shows that rs2187331 has an allele specific cis-regulatory function and influences the expression of lipid related genes in adipose.
OBJECTIVE: There is increasing physiological evidence in rodents connecting the neuropeptide galanin to triglyceride (TG) levels. We hypothesized that variation in the galanin preproprotein (GAL) gene may contribute to hypertriglyceridemia (HTG) in humans. METHODS AND RESULTS: We investigated GAL as a TG candidate gene by genotyping 4 tagSNPs in Dutch, Finnish, and Mexican familial combined hyperlipidemia (FCHL) families as well as in white combined hyperlipidemia cases/controls (n=2471). The common allele of rs2187331, residing in the promoter region of GAL, was significantly associated with HTG (probability value=0.00038). In an unascertained population sample of 4463 Finnish males, the rare allele of rs2187331 was associated with higher TGs (probability value=0.0028 to 0.00016). We also observed an allele specific difference with rs2187331 in reporter gene expression and nuclear factor binding in vitro. Furthermore, we detected differential expression of many key lipid genes in adipose tissue based on rs2187331 genotypes. CONCLUSIONS: The SNP rs2187331 is associated with HTG in FCHL and white combined hyperlipidemia cases/controls and influences TG levels in the population. Further studies are warranted to elucidate the allelic difference observed between FCHL and the general population. Functional evidence shows that rs2187331 has an allele specific cis-regulatory function and influences the expression of lipid related genes in adipose.
Authors: Rossitza P Naoumova; Stephanie A Bonney; Sophie Eichenbaum-Voline; Hetal N Patel; Bethan Jones; Emma L Jones; Joanna Amey; Susan Colilla; Clare K Y Neuwirth; Rebecca Allotey; Mary Seed; D John Betteridge; David J Galton; Nancy J Cox; Graeme I Bell; James Scott; Carol C Shoulders Journal: Arterioscler Thromb Vasc Biol Date: 2003-09-18 Impact factor: 8.311
Authors: J J Holst; M Bersani; A Hvidberg; U Knigge; E Christiansen; S Madsbad; H Harling; H Kofod Journal: Diabetologia Date: 1993-07 Impact factor: 10.122
Authors: Sarah F Leibowitz; Jordan T Dourmashkin; Guo-Qing Chang; James O Hill; Ellis C Gayles; Susan K Fried; Jian Wang Journal: Brain Res Date: 2004-05-22 Impact factor: 3.252
Authors: Rebecca Mar; Päivi Pajukanta; Hooman Allayee; Martine Groenendijk; Geesje Dallinga-Thie; Ronald M Krauss; Janet S Sinsheimer; Rita M Cantor; Tjerk W A de Bruin; Aldons J Lusis Journal: Circ Res Date: 2004-03-04 Impact factor: 17.367
Authors: Martijn C G J Brouwers; Marleen M J van Greevenbroek; Coen D A Stehouwer; Jacqueline de Graaf; Anton F H Stalenhoef Journal: Nat Rev Endocrinol Date: 2012-02-14 Impact factor: 43.330
Authors: Christopher L Plaisier; Steve Horvath; Adriana Huertas-Vazquez; Ivette Cruz-Bautista; Miguel F Herrera; Teresa Tusie-Luna; Carlos Aguilar-Salinas; Päivi Pajukanta Journal: PLoS Genet Date: 2009-09-11 Impact factor: 5.917
Authors: Olga Karatayev; Jessica Baylan; Valerie Weed; Siyi Chang; David Wynick; Sarah F Leibowitz Journal: Alcohol Clin Exp Res Date: 2009-10-23 Impact factor: 3.455
Authors: Scott Davidson; Marissa Lear; Lynne Shanley; Benjamin Hing; Amanda Baizan-Edge; Annika Herwig; John P Quinn; Gerome Breen; Peter McGuffin; Andrew Starkey; Perry Barrett; Alasdair MacKenzie Journal: Neuropsychopharmacology Date: 2011-06-29 Impact factor: 7.853
Authors: Adriana Huertas-Vazquez; Christopher L Plaisier; Ruishuang Geng; Blake E Haas; Jenny Lee; Marleen M Greevenbroek; Carla van der Kallen; Tjerk W A de Bruin; Marja-Riitta Taskinen; Kumar N Alagramam; Päivi Pajukanta Journal: Hum Genet Date: 2009-10-09 Impact factor: 4.132